Glutamate-blood cardioplegia improves ATP preservation in human myocardium. 1987

O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
USSR Cardiology Research Center, Moscow.

Two groups of patients subjected to radical correction of Fallot's tetrad and defects of interventricular septum were investigated to ascertain whether the addition of glutamic acid to blood cardioplegic perfusate could improve preservation of myocardial ATP during cardiac arrest. In the control group (17 patients) the myocardial protection was performed by repeated infusions of cold blood potassium cardioplegic solution; in the 2nd group (24 patients) cardioplegic perfusate containing glutamic acid (20 mmol/l) was used. Left ventricular biopsies were taken during the first minute after cross-clamping of the aorta and before the release of the aortic clamp to determine ATP, glutamate and lactate. The cross-clamping time averaged 32 min in both groups. In the patients of the control group the losses of ATP correlated with the decrease in glutamate during the clamping period. A maintenance of a higher myocardial glutamate content by glutamate-containing cardioplegic perfusate prevented ATP fall or increased its level in patients of the 2nd group. There was no significant difference in lactate levels between the two groups by the end of the cardiac arrest. We conclude that enrichment of blood cardioplegic solution by glutamic acid, which may act as a substrate for anaerobic energy production, provides more effective myocardial protection during ischemic heart arrest.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002314 Cardioplegic Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. Cardioplegic Solution,Solution, Cardioplegic,Solutions, Cardioplegic
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005971 Glutamates Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure. Glutamic Acid Derivatives,Glutamic Acids,Glutaminic Acids
D006324 Heart Arrest, Induced A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate). Cardiac Arrest, Induced,Cardioplegia,Induced Cardiac Arrest,Induced Heart Arrest,Cardioplegias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D013771 Tetralogy of Fallot A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS. Fallot's Tetralogy,Tetralogy, Fallot's,Fallot Tetralogy,Fallots Tetralogy,Tetralogy, Fallot,Tetralogy, Fallots

Related Publications

O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
January 1993, The Annals of thoracic surgery,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
April 1983, Chest,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
May 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
January 1987, Grudnaia khirurgiia (Moscow, Russia),
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
November 1994, The Annals of thoracic surgery,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
February 1985, The Annals of thoracic surgery,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
January 1984, The Journal of cardiovascular surgery,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
November 1990, The Annals of thoracic surgery,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
June 1994, The Annals of thoracic surgery,
O I Pisarenko, and V F Portnoy, and I M Studneva, and A D Arapov, and A N Korostylev
August 1980, Circulation,
Copied contents to your clipboard!